Abbvie Inc.
North Chicago, IL
- UEI
- VAFXUGJBLML4
- CAGE
- 7EVR9
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1 N Waukegan Rd #343, North Chicago, IL 60064, USA
- Website
- abbvie.com
- Founded
- 2013
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | — | — |
| Aphena Pharma Solutions Holdings, Inc. | Cookeville, TN | 561910 Packaging and Labeling Services |
| Horizon Therapeutics Usa, Inc. | Deerfield, IL | 325412 Pharmaceutical Preparation Manufacturing |
| Takeda Pharmaceutical Company LIMITED | — | — |
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
About the company
Abbvie Inc., headquartered in North Chicago, Illinois, is a global pharmaceutical company that develops, manufactures, and distributes a broad portfolio of pharmaceutical products, including treatments for immunology, oncology, virology, and other therapeutic areas. As a for-profit corporate entity registered with SAM.gov since September 2021, Abbvie operates as a parent company with multiple subsidiaries and maintains an active federal vendor registration status through September 9, 2026. While Abbvie is a major pharmaceutical supplier in the healthcare industry, the company's current federal contracting profile reflects limited direct engagement with federal contract and grant award vehicles at the prime level.
Based on the available federal award data, Abbvie Inc. has not held any prime federal contracts during the review period. The company's status as registered in SAM.gov without active prime contract awards indicates that any federal contracting activity may be limited to subcontractor roles or smaller-scale engagements that fall below the reporting thresholds typically captured in federal award databases. Without documented prime contract awards, the specific details regarding contract types, funding agencies, partnering arrangements, and potential small business set-asides cannot be provided at this time. This gap in prime contract activity suggests that Abbvie's federal engagement may occur primarily through other channels or procurement mechanisms not reflected in the current award history.
Similarly, Abbvie Inc. does not appear in the federal award database as a prime recipient of federal grants during the current reporting period. The absence of grant award documentation indicates that Abbvie has not served as a direct grantee through federal grant programs administered by agencies such as the National Institutes of Health, the Department of Health and Human Services, or other federal grant-making bodies. Without identified prime grant awards, details regarding grant funding amounts, specific therapeutic areas supported, partnering research institutions, or applicable grant programs cannot be documented. This suggests that any collaborative research or development efforts involving federal funding may be structured through alternative mechanisms or may not meet the public reporting requirements for federal grants.
Abbvie Inc. does not currently hold any federal Indefinite Delivery/Indefinite Quantity (IDV) contracts, including General Services Administration schedules, blanket purchase agreements, or other federal contract vehicles that would enable task order issuance by federal agencies. The absence of held IDVs indicates that the company has not established pre-negotiated contracting instruments that would allow multiple agencies to issue task orders for goods or services. This structural gap in Abbvie's federal contracting portfolio means that any pharmaceutical products or services the company provides to federal agencies would likely be procured through traditional competitive solicitations, direct purchases at established commercial prices, or other ad-hoc procurement methods rather than through standing IDV arrangements.
Quick answers
Is Abbvie Inc. registered in SAM.gov?
Abbvie Inc.'s SAM.gov registration expired on September 9, 2026.
On GovTribe
See Abbvie Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors